266 related articles for article (PubMed ID: 25812009)
1. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH; Brenner LN; Kaur V; Figueroa K; Schroeder P; Huerta-Chagoya A; ; ; Udler MS; Leong A; Mercader JM; Florez JC
Diabetologia; 2023 Jul; 66(7):1260-1272. PubMed ID: 37233759
[TBL] [Abstract][Full Text] [Related]
3.
Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
[TBL] [Abstract][Full Text] [Related]
4. The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide.
Chen L; Li JH; Kaur V; Muhammad A; Fernandez M; Hudson MS; Goldfine AB; Florez JC
Diabet Med; 2020 Dec; 37(12):2124-2130. PubMed ID: 31709648
[TBL] [Abstract][Full Text] [Related]
5. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
Sobieraj DM; Freyer CW
Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
[TBL] [Abstract][Full Text] [Related]
6. A Polygenic Score for Type 2 Diabetes Risk Is Associated With Both the Acute and Sustained Response to Sulfonylureas.
Li JH; Szczerbinski L; Dawed AY; Kaur V; Todd JN; Pearson ER; Florez JC
Diabetes; 2021 Jan; 70(1):293-300. PubMed ID: 33106254
[TBL] [Abstract][Full Text] [Related]
7. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.
Walford GA; Davis J; Warner AS; Ackerman RJ; Billings LK; Chamarthi B; Fanelli RR; Hernandez AM; Huang C; Khan SQ; Littleton KR; Lo J; McCarthy RM; Rhee EP; Deik A; Stolerman E; Taylor A; Hudson MS; Wang TJ; Altshuler D; Grant RW; Clish CB; Gerszten RE; Florez JC
Metabolism; 2013 Dec; 62(12):1772-8. PubMed ID: 23953891
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.
Cefalu WT; Schneider DJ; Carlson HE; Migdal P; Gan Lim L; Izon MP; Kapoor A; Bell-Farrow A; Terry JG; Sobel BE
Diabetes Care; 2002 Dec; 25(12):2123-8. PubMed ID: 12453948
[TBL] [Abstract][Full Text] [Related]
9. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
[TBL] [Abstract][Full Text] [Related]
10. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.
Bi Y; Tong GY; Yang HJ; Cai MY; Ma JH; Liang J; Xin B; Miao H; Peng ZH; Zhu DL
Diabetes Metab Res Rev; 2013 Nov; 29(8):664-72. PubMed ID: 23955995
[TBL] [Abstract][Full Text] [Related]
12. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.
Dawed AY; Yee SW; Zhou K; van Leeuwen N; Zhang Y; Siddiqui MK; Etheridge A; Innocenti F; Xu F; Li JH; Beulens JW; van der Heijden AA; Slieker RC; Chang YC; Mercader JM; Kaur V; Witte JS; Lee MTM; Kamatani Y; Momozawa Y; Kubo M; Palmer CNA; Florez JC; Hedderson MM; 't Hart LM; Giacomini KM; Pearson ER; ;
Diabetes Care; 2021 Dec; 44(12):2673-2682. PubMed ID: 34607834
[TBL] [Abstract][Full Text] [Related]
15. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Kuss O; Müssig K; Burkart V; Szendroedi J; Kotzka J; Knebel B; Al-Hasani H; Roden M;
Diabetologia; 2019 Feb; 62(2):286-291. PubMed ID: 30413829
[TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
Jeppesen J; Zhou MY; Chen YD; Reaven GM
Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
19. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
20. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
